These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2577382)

  • 21. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
    Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
    Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
    Watanabe Y; Iwa T
    J Biol Response Mod; 1987 Apr; 6(2):169-80. PubMed ID: 3585412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro.
    Uchida A; Hoshino T
    Cancer; 1980 Feb; 45(3):476-83. PubMed ID: 6965464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
    Katada H; Nishikawa K; Yoneda T; Kitamura H; Nakajima A; Mikami R
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
    Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of some nonspecific immunological parameters in patients with oral cavity carcinoma undergoing cryosurgery].
    Airoldi M; Gandolfo S; Salassa B; Troglia G; Pecchio F; Manca A; Fazio M
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1334-40. PubMed ID: 6969599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specific immunologic stimulation induced by cryosurgery of spinocellular tumors & of the oral cavity].
    Airoldi M; Mastromatteo V; Negri L; Fazio M; Gandolfo S
    Boll Soc Ital Biol Sper; 1982 Sep; 58(18):1213-9. PubMed ID: 6753876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies of immunological function in patients with ovarian cancer].
    Hamai J; Yakushiji M; Miyahara K; Okura N; Tazaki T; Nishimura H; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1875-82. PubMed ID: 2997348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of treatment results for floor-of-mouth cancer.
    Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
    Luh KT; Yang PC; Kuo SH; Chang DB; Yu CJ; Lee LN
    Cancer; 1992 Feb; 69(3):674-9. PubMed ID: 1309678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-lymphocyte subsets in primary lung cancer.
    Tsuyuguchi I; Shiratsuchi H; Fukuoka M
    Jpn J Clin Oncol; 1987 Mar; 17(1):13-7. PubMed ID: 3494139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The alternation of peripheral lymphocyte subsets in head and neck carcinoma].
    Mitarai K; Tsukuda M; Mochimatsu I; Kubota A; Sawaki S
    Gan No Rinsho; 1986 Jul; 32(8):849-54. PubMed ID: 3747146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of selective intra-arterial infusion of OK-432 against renal cell cancers].
    Fujioka T; Tanji S; Koike H; Kumagai K; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
    Hinyokika Kiyo; 1987 Jun; 33(6):832-7. PubMed ID: 3673835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y; Toki H; Okabe K; Fujii M; Tamai M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
    J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.